Skip to main content
SpringerLink
Log in

The antiviral activity of the milk protein lactoferrin against the human immunodeficiency virus type 1

  • Published:
Biometals Aims and scope Submit manuscript

Abstract

Milk forms a rich source of biologically interesting components and the protein fraction is known to facilitate many different biological functions. In this manuscript, we review the antiviral properties of the milk protein lactoferrin (LF). In particular, we will describe its antiviral activity against the human immunodeficiency virus type 1 (HIV-1).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Baba M, Pauwels R, Balzarini J et al. 1988 Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro. Proc Natl Acad Sci USA 85, 6132-6136.

    PubMed  Google Scholar 

  • Berkhout B, Derksen GC, Back NK et al. 1997 Structural and functional analysis of negatively charged milk proteins with anti-HIV activity. AIDS Res Hum Retroviruses 1, 1101-1107.

    Google Scholar 

  • Berkhout B, Das AT. 1998 Similarity of chemokines charge and the V3 domain of HIV-1 env protein. Emerg Infect Dis 4, 335-336.

    PubMed  Google Scholar 

  • Berkhout B, van Wamel JL, Beljaars L et al. 2002 Characterization of the anti-HIV effects of native lactoferrin and other milk proteins and protein derived peptides. Antiviral Res 55, 341-355.

    PubMed  Google Scholar 

  • Blair WS, Lin PF, Meanwell NA et al. 2000 HIV-1 entry-an expanding portal for drug discovery. Drug Discovery Today 5, 183-194.

    PubMed  Google Scholar 

  • Cormier EG, Persuh M, Thompson DA et al. 2000 Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120. Proc Natl Acad Sci USA 97, 5762-5767.

    PubMed  Google Scholar 

  • De Jong JJ, De Ronde A, Keulen W et al. 1992 Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution. J Virol 11, 6777-6780.

    Google Scholar 

  • Doranz BJ, Grovit-Ferbas K, Sharron MP et al. 1997 A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor. J Exp Med 8, 1395-400.

    Google Scholar 

  • Dziuba J, Minkiewicz P, Nalecz D et al. 1999 Database of biologically active peptide sequences. Nahrung 43, 190-195.

    PubMed  Google Scholar 

  • Farzan M, Mirzabekov T, Kolchinsky P et al. 1999 Tyrosine Sulfation of the Amino Terminus of CCR5 Facilitates HIV-1 Entry. Cell 96, 667-676.

    PubMed  Google Scholar 

  • Fouchier RA, Groenink M, Kootstra NA et al. 1992 Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J Virol 5, 3183-3187.

    Google Scholar 

  • Hambraeus L. 1992 In Adv. Dairy Chem, Fox, P.F., eds. Elsevier Science Publishers Ltd. London 1, 457-490.

    Google Scholar 

  • Harmsen MC, Swart PJ, de Bethune MP et al. 1995 Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. J Infect Dis 2, 380-388.

    Google Scholar 

  • Jiang S. 1997 A survey of the sexual values and behavior among urban unmarried young people in the nineties. Chin J Popul Sci 3, 265-268.

    Google Scholar 

  • Kajumo F, Thompson DA, Guo Y et al. 2000 Entry of R5X4 and X4 Human Immunodeficiency Virus Type 1 strains is mediated by negatively charged and tyrosine residues in the amino-terminal domain and the second extracellular loop of CXCR4. Virology 271, 240-247.

    PubMed  Google Scholar 

  • Kwong PD, Wyatt R, Sattentau QJ et al. 2000 Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus. J Virol 74, 1961-1972.

    PubMed  Google Scholar 

  • Lash JA, Coates TD, Lafuze J et al. 1983 Plasma lactoferrin reflects granulocyte activation in vivo. Blood 61, 885-888.

    PubMed  Google Scholar 

  • Lederman S, Gulick R, Chess L. 1989 Dextran sulfate and heparin interact with CD4 molecules to inhibit the binding of coat protein (gp120) of HIV. J Immunol 143, 1149-1154.

    PubMed  Google Scholar 

  • Meisel H. 1997 Biochemical properties of regulatory peptides derived from milk proteins Biopolymers 2, 119-128.

    Google Scholar 

  • Moriuchi M, Moriuchi H. 2001 A milk protein lactoferrin enhances human T cell leukemia virus-type I and suppresses HIV-1 infection. J Immunol 166, 4231-4236.

    PubMed  Google Scholar 

  • Moulard M, Lortat-Jacob H, Mondor I et al. 2000 Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120. J Virol 74, 1948-1960.

    PubMed  Google Scholar 

  • Moyle GJ, Back D. 2001 Principles and practice of HIV-protease inhibitor pharmacoenhancement. HIV Med 2, 105-113.

    PubMed  Google Scholar 

  • Newburg DS, Viscidi RP, Ruff A et al. 1992 A human milk factor inhibits binding of human immunodeficiency virus to the CD4 receptor. Pediatr Res 31, 22-28.

    PubMed  Google Scholar 

  • Ng TB, Lam TL, Au TK et al. 2001 Inhibition of human immunodeficiency virus type 1 reverse transcriptase, protease and integrase by bovine milk proteins. Life Sci 19, 2217-2223.

    Google Scholar 

  • Nuijens JH, Abbink JJ, Wachtfogel YT et al. 1992 Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis. J Lab Clin Med 119, 159-168.

    PubMed  Google Scholar 

  • Puddu P, Borghi P, Gessani S et al. 1998 Antiviral effect of bovine lactoferrin saturated with metal ions on early steps of human immunodeficiency virus type 1 infection. Int J Biochem Cell Biol 30, 1055-1062.

    PubMed  Google Scholar 

  • Rizzuto CD, Wyatt R, Hernandez-Ramos N et al. 1998 A Conserved HIV gp120 Glycoprotein Structure Involved in Chemokine Receptor Binding. Science 280, 1949-1953.

    PubMed  Google Scholar 

  • Roderiquez G, Oravecz T, Yanagishita M et al. 1995 Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41. J Virol 69, 2233-2239.

    PubMed  Google Scholar 

  • Sattentau QJ, Clapham PR, Weiss RA et al. 1988 The human and simian immunodeficiency viruses HIV-1, HIV-2 and SIV interact with similar epitopes on their cellular receptor, the CD4 molecule. AIDS 2, 101-115.

    PubMed  Google Scholar 

  • Schols D, Struyf S, Van Damme J et al. 1997 Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. J ExpMed 186, 1383-1388.

    Google Scholar 

  • D'Souza MP, Cairns JS, Plaeger SF. 2000 Current evidence and future directions for targeting HIV entry: therapeutic and prophylactic strategies. JAMA 284, 215-222.

    PubMed  Google Scholar 

  • Squires KE 2001. An introduction to nucleoside and nucleotide analogues. Antivir Ther 6 (Suppl 3), 1-14.

    Google Scholar 

  • Swart PJ, Kuipers EM, Smit C et al. 1998 Antiviral activity of lactoferrin. Adv Exp Med Biol 443, 205-213.

    PubMed  Google Scholar 

  • Swart PJ, Harmsen MC, Kuipers ME et al. 1999 Charge modification of plasma and milk proteins results in antiviral active compounds. J Pept Sci 5, 563-576.

    PubMed  Google Scholar 

  • Swart PJ, Kuipers ME, Smit C et al. 1999 Antiviral effects of milk proteins: acylation results in polyanionic compounds with potent activity against human immunodeficiency virus types 1 and 2 in vitro. AIDS Res Hum Retroviruses 12, 769-775.

    Google Scholar 

  • Ueno R, Kuno S. 1987 Anti-HIV synergism between dextran sulphate and zidovudine. Lancet 2, 796-797.

    Google Scholar 

  • Van Heeswijk RP, Veldkamp A, Mulder JW et al. 2001 Combination of protease inhibitors for the treatment of HIV-1-infected patients: a review of pharmacokinetics and clinical experience. Antiviral Therapy 4, 201-229.

    Google Scholar 

  • Volberding PA. 1999 Advances in the medical management of patients with HIV-1 infection: an overview. AIDS 13 (Suppl 1), S1-S9.

    Google Scholar 

  • Wang H, Ye X, Ng TB. 2000 First demonstration of an inhibitory activity of milk proteins against human immunodeficiency virus-1 reverse transcriptase and the effect of succinylation. Life Sci 67, 2745-2752.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Human Retrovirology, Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105 AZ, Amsterdam, The Netherlands

    Ben Berkhout

  2. Department of Product Technology, NIZO food research, P.O. Box 20, 6710 BA, Ede, The Netherlands

    René Floris & Servaas Visser

  3. Instituto de Fermentaciones Industriales (CSIC), Juan de la Cierva 3, 28006, Madrid, Spain

    Isidra Recio

Authors
  1. Ben Berkhout
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. René Floris
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Isidra Recio
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Servaas Visser
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ben Berkhout.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Berkhout, B., Floris, R., Recio, I. et al. The antiviral activity of the milk protein lactoferrin against the human immunodeficiency virus type 1. Biometals 17, 291–294 (2004). https://doi.org/10.1023/B:BIOM.0000027707.82911.be

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:BIOM.0000027707.82911.be

Search

Navigation